|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.16 SEK | +4.30% |
|
-6.22% | +69.86% |
| Apr. 18 | Diamyd Medical Raises SEK57 Million in Rights Issue | MT |
| Apr. 12 | Recruitment Milestone Reaches in Diamyd® Phase 3 Trial | CI |
Diamyd Medical AB (publ) reported earnings results for the fourth quarter ended August 31, 2023. For the fourth quarter, the company reported sales was SEK 0.074 million compared to SEK 0.059 million a year ago. Revenue was SEK 11.17 million compared to SEK 1.16 million a year ago.
Net loss was SEK 21.65 million compared to SEK 36.73 million a year ago. Basic loss per share from continuing operations was SEK 0.3 compared to SEK 0.5 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +69.86% | 106M | |
| +8.96% | 105B | |
| -1.43% | 104B | |
| +4.40% | 22.94B | |
| -12.15% | 22.34B | |
| -4.36% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +6.79% | 14.16B | |
| +38.61% | 12.63B |
DIAMYD MEDICAL AB 
